top of page

Germany's Münster hosts the third General Assembly of PSIONIC



The third PSIONIC General Assembly, held on July 10-11 in Münster Germany, brought together representatives from the project's consortium. Discussions focused on the project's progresses and the research results. The group also discussed plans for the upcoming year and the potential for future collaboration.


Martin Winter, a well-known German Chemist and Scientist, welcomed the consortium to Münster, which has a significant research area for green battery technology. During the first day of the meeting, Margaud Lecuyer (BlueSolutions) gave an opening statement. The meeting then moved on to presentations from the following work packages: system definition and benchmarking (WP1, led by BlueSolutions), polymer-based electrolyte synthesis and scale-up (WP2, led by SPECIFIC POLYMERS), electrode and interface formulation (WP3, led by the National Institute of Chemistry) Prototype cells and modules (WP4, led by BlueSolutions) and Recycling, safety test and LCA (WP5, led by Accurec).


Additionally, the partners were able to visit the Münster Electrochemical Energy Technology (MEET) battery laboratory on the first day. MEET is a research facility for the development of energy storage technologies and related materials. The partners had the opportunity to see the state-of-the-art equipment and discuss their research with the experts. The day came to an end at a well-known German restaurant hosted by Dr. Martin Winter, who also gave the PSIONIC Consortium a lovely evening tour of Münster. He took the group to see the historic district of the city and its exquisitely preserved buildings.


The second day of the meeting was spent discussing Work Package 6 on Dissemination, Communication, and Exploitation and Work Package 7 on Project Coordination and Management. The discussion centred on the specifics of the assignments and the tools required to complete them. The group also discussed the project's schedule of events and the due dates for the various tasks. The international advisory board joined the meeting on this second day in order to bring its expertise and help for a better adaptation of the cells developed to the needs of alternative markets like aerospace or trains.


The PSIONIC General Assembly's two days were, overall, very forward-thinking and full of fresh concepts. In order to speed-up crucial activities, efficient ways of maximising interaction among partners' varying specializations were investigated. We appreciate the participation of all of our partners. The two-day discussion about the significance of PSIONIC’s research was successful in achieving the objectives of our project. To advance the project, key focus areas were identified, and creative solutions were developed.


We eagerly anticipate our upcoming project meeting.

Comments


bottom of page